Skip to main content

Table 4 (abstract P538). Vedolizumab therapy outcomes and clinical characteristics (n = 28)

From: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

Back to article page